| Psychological Distress and COVID-19–Related Stressors Reported in a Longitudinal Cohort of US Adults in April and July 2020 EE McGinty, R Presskreischer, KE Anderson, H Han, CL Barry JAMA 324 (24), 2555-2557, 2020 | 228 | 2020 |
| Reports of Forgone Medical Care Among US Adults During the Initial Phase of the COVID-19 Pandemic KE Anderson, EE McGinty, R Presskreischer, CL Barry JAMA Network Open 4 (1), e2034882-e2034882, 2021 | 176 | 2021 |
| Change Over Time in Public Support for Social Distancing, Mask Wearing, and Contact Tracing to Combat the COVID-19 Pandemic Among US Adults, April to November 2020 CL Barry, KE Anderson, H Han, R Presskreischer, EE McGinty American Journal of Public Health 111 (5), 937-948, 2021 | 35 | 2021 |
| Physician Network Breadth and Plan Quality Ratings in Medicare Advantage AP Sen, MK Meiselbach, KE Anderson, BJ Miller, D Polsky JAMA Health Forum 2 (7), e211816-e211816, 2021 | 25 | 2021 |
| US Adults’ Beliefs About Harassing or Threatening Public Health Officials During the COVID-19 Pandemic RJ Topazian, EE McGinty, H Han, AS Levine, KE Anderson, ... JAMA Network Open 5 (7), e2223491-e2223491, 2022 | 23 | 2022 |
| Biosimilar uptake in Medicare Part B varied across hospital outpatient departments and physician practices: the case of filgrastim MP Socal, KE Anderson, A Sen, G Bai, GF Anderson Value in Health 23 (4), 481-486, 2020 | 22 | 2020 |
| Improving Prior Authorization in Medicare Advantage KE Anderson, M Darden, A Jain JAMA 328 (15), 1497-1498, 2022 | 18 | 2022 |
| Quality of Preventive and Chronic Illness Care for Insured Adults With Opioid Use Disorder KE Anderson, GC Alexander, L Niles, SH Scholle, B Saloner, SM Dy JAMA Network Open 4 (4), e214925-e214925, 2021 | 12 | 2021 |
| Prescribing of low‐versus high‐cost Part B drugs in Medicare Advantage and traditional Medicare KE Anderson, D Polsky, S Dy, AP Sen Health services research 57 (3), 537-547, 2022 | 11 | 2022 |
| Public Support for Social Safety-Net Policies for COVID-19 in the United States, April 2020 CL Barry, H Han, R Presskreischer, KE Anderson, EE McGinty American Journal of Public Health 110 (12), 1811-1813, 2020 | 11 | 2020 |
| Quality of Buprenorphine Care for Insured Adults With Opioid Use Disorder KE Anderson, B Saloner, J Eckstein, CE Chaisson, SH Scholle, L Niles, ... Medical Care 59 (5), 393-401, 2021 | 9 | 2021 |
| Eating disorders in the US Medicare population R Presskreischer, JE Steinglass, KE Anderson International Journal of Eating Disorders 55 (3), 362-371, 2022 | 8 | 2022 |
| Medicare Advantage Coverage Restrictions for the Costliest Physician-Administered Drugs. KE Anderson, GC Alexander, C Ma, SM Dy, AP Sen American Journal of Managed Care 28 (7), 2022 | 7 | 2022 |
| Payment incentives and the use of higher-cost drugs: a retrospective cohort analysis of intravenous iron in the Medicare population BC Hambley, KE Anderson, SP Shanbhag, AP Sen 3rd, G Anderson The American journal of managed care 26 (12), 516-522, 2020 | 7 | 2020 |
| Association Between Open Payments–Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US AM Nguyen, KE Anderson, G Anderson, TV Johnson JAMA ophthalmology 140 (9), 855-862, 2022 | 5 | 2022 |
| Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein R MacDonell-Yilmaz, K Anderson, B DeNardo, P Sprinz, WV Padula The Journal of Pediatrics 225, 80-89. e4, 2020 | 5 | 2020 |
| Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? RB McQueen, KE Anderson, JF Levy, JJ Carlson PharmacoEconomics, 1-7, 2023 | 3 | 2023 |
| Catastrophic Coverage in the Medicare Part D Drug Benefit: Which Beneficiaries Need It and How Much Are They Spending? AP Sen, S Parasrampuria, KE Anderson, G Anderson | 2 | 2020 |
| Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare Drug Price Negotiation Program MJ DiStefano, A Zemplenyi, KE Anderson, ND Mendola, KV Nair, ... Expert Review of Pharmacoeconomics & Outcomes Research, 2024 | 1 | 2024 |
| Is there an advantage? Considerations for researchers studying the effects of the type of Medicare coverage LH Nicholas, D Polsky, M Darden, J Xu, K Anderson, DJ Meyers Health Services Research, 2023 | 1 | 2023 |
